Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

EU Antitrust Regulators Clear With Conditions Ali Group’s $3.4B Bid For Welbilt

-Reuters

byBenzinga Newsdesk

June 17, 2022

1 minute read

-Reuters

Helius Medical’s Neuromodulation Stimulator Nabs FDA Breakthrough Tag

By Vandana Singh

Today, 5:43 AM

The FDA has granted Breakthrough Device Designation to Helius Medical Technologies Inc’s (NASDAQ:HSDT) PoNS device. Related content: Benzinga’s Full FDA Calendar. The designation…

HSDT

Rosenblatt Maintains Buy on Live Nation Entertainment, Lowers Price Target to $101

By Benzinga Newsdesk

Today, 5:43 AM

Rosenblatt analyst Barton Crockett maintains Live Nation Entertainment (NYSE:LYV) with a Buy and lowers the price target from $138 to $101.

LYV

ClearPoint Neuro Announces First Patient Enrolled In Glioblastoma Trial Using ClearPoint Prism Neuro Laser Therapy System At Skåne University Hospital In Sweden

By Benzinga Newsdesk

Today, 5:43 AM

ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced enrollment of the first patient in a Glioblastoma

CLPT

Recap: Orthofix Medical Q4 Earnings

By Benzinga Insights

Today, 5:43 AM

Orthofix Medical (NASDAQ:OFIX) reported its Q4 earnings results on Friday, February 25, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

OFIX

EU Antitrust Regulators Clear With Conditions Ali Group’s $3.4B Bid For Welbilt

Related Posts

Helius Medical’s Neuromodulation Stimulator Nabs FDA Breakthrough Tag

Rosenblatt Maintains Buy on Live Nation Entertainment, Lowers Price Target to $101

ClearPoint Neuro Announces First Patient Enrolled In Glioblastoma Trial Using ClearPoint Prism Neuro Laser Therapy System At Skåne University Hospital In Sweden

Recap: Orthofix Medical Q4 Earnings